Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
68 patents granted to the 3 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to SIGA Technologies Inc.’s names, not what it holds today.
Patents granted
68
68 utility, 1976 to Dec 31, 2025
Granted in 2025
1
Against 1 in 2024 and 1 in 2023
Applications published
64
since 2001, to Dec 31, 2025
Names they are printed under
3
its own name, a former name
By yearGrantedApplications published
'11'12'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name3 counted
Siga Technologies, Inc. its own name
US, as the owner printed on each patent
63 publishedSIGA Pharmaceuticals, Inc. a former name
US, as the owner printed on each patent
0 publishedSIGA TECHNOLOGIES, INC. its own name
named as the applicant on its applications, in US
1 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Oct 7, 2025 | 12,433,868 | Polymorphic forms of ST-246 and methods of preparation | Pharmaceuticals | Siga Technologies, Inc. |
| Feb 6, 2024 | 11,890,270 | Polymorphic forms of ST-246 and methods of preparation | Pharmaceuticals | Siga Technologies, Inc. |
| Oct 10, 2023 | 11,779,566 | ST-246 (tecovirimat monohydrate) suspension formulations | Pharmaceuticals | Siga Technologies, Inc. |
| Sep 6, 2022 | 11,433,051 | ST-246 (tecovirimat monohydrate) suspension formulations | Pharmaceuticals | Siga Technologies, Inc. |
| Mar 2, 2021 | 10,933,050 | Polymorphic forms of ST-246 and methods of preparation | Pharmaceuticals | Siga Technologies, Inc. |
| Dec 15, 2020 | 10,864,282 | ST-246 liquid formulations and methods | Pharmaceuticals | Siga Technologies, Inc. |
| Jul 21, 2020 | 10,716,759 | Rehydration of micronized tecovirimat monohydrate | Pharmaceuticals | Siga Technologies, Inc. |
| May 26, 2020 | 10,662,155 | Methods of preparing tecovirimat | Organic fine chemistry | Siga Technologies, Inc. |
| Mar 3, 2020 | 10,576,165 | ST-246 liquid formulations and methods | Pharmaceuticals | Siga Technologies, Inc. |
| Sep 10, 2019 | 10,406,137 | Polymorphic forms of ST-246 and methods of preparation | Pharmaceuticals | Siga Technologies, Inc. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| May 16, 2024 | 2024/0156782 | POLYMORPHIC FORMS OF ST-246 AND METHODS OF PREPARATION | Pharmaceuticals | Siga Technologies, Inc. · patent 12,433,868 granted from it |
| Jan 19, 2023 | 2023/0016581 | ST-246 (tecovirimat monohydrate) SUSPENSION FORMULATIONS | Pharmaceuticals | Siga Technologies, Inc. · patent 11,779,566 granted from it |
| Jul 15, 2021 | 2021/0212987 | ST-246 (tecovirimat monohydrate) SUSPENSION FORMULATIONS | Pharmaceuticals | Siga Technologies, Inc. · patent 11,433,051 granted from it |
| May 13, 2021 | 2021/0137885 | POLYMORPHIC FORMS OF ST-246 AND METHODS OF PREPARATION | Pharmaceuticals | Siga Technologies, Inc. · patent 11,890,270 granted from it |
| May 7, 2020 | 2020/0138974 | ST-246 LIQUID FORMULATIONS AND METHODS | Pharmaceuticals | Siga Technologies, Inc. · patent 10,864,282 granted from it |
| Dec 19, 2019 | 2019/0380966 | REHYDRATION OF MICRONIZED TECOVIRMIMAT MONOHYDRATE | Pharmaceuticals | Siga Technologies, Inc. · patent 10,716,759 granted from it |
| Nov 14, 2019 | 2019/0343799 | POLYMORPHIC FORMS OF ST-246 AND METHODS OF PREPARATION | Pharmaceuticals | Siga Technologies, Inc. · patent 10,933,050 granted from it |
| Mar 14, 2019 | 2019/0077753 | METHODS OF PREPARING TECOVIRIMAT | Organic fine chemistry | Siga Technologies, Inc. · patent 10,662,155 granted from it |
| Feb 7, 2019 | 2019/0038767 | ST-246 LIQUID FORMULATIONS AND METHODS | Pharmaceuticals | Siga Technologies, Inc. · patent 10,576,165 granted from it |
| Nov 1, 2018 | 2018/0311213 | POLYMORPHIC FORMS OF ST-246 AND METHODS OF PREPARATION | Pharmaceuticals | Siga Technologies, Inc. · patent 10,406,137 granted from it |
What it applied for, 2024 to 2025: Pharmaceuticals 1.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.